AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06653634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNF Inhibitor
Description: Gradual withdrawal of the medication
Study NCT06667505 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Choice-ICD
Description: The eHealth intervention theoretically driven, interactive and provides personalised information to patients and family members when and where they wish to access it. Five short (2-3 minutes) videos, involving patients, caregivers and professionals, are uploaded onto the APP, alongside animation clips and useful links to online resources. A discussion forum will be accessible for participants using the APP, which will be closely moderated by the researcher, who will ensure any concerning posts or dialogue are promptly removed, and the necessary action is taken. The diary function will allow patients to record and be reminded of future appointments. Patients and family members will engage with the intervention for 3 months.
Study NCT06663371 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Physical Fitness
Description: The single module training paradigm followed a circuit-style format, with each training module consisting of 6 to 8 distinct exercise movements. Taking the INT training intervention on Mondays as an example, the training protocol involved completing one major module (e.g., plyometric exercises) before transitioning to another module (e.g., core stability exercises). Specific exercise methods, such as box jumps, were performed until all sets were completed before moving on to the next exercise (e.g., continuous depth jumps).
Study NCT06663371 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Traditional Physical Training
Description: In the fundamental strength training, a circuit training modality is employed, with each training segment comprising 5 to 7 exercise movements. For instance, a series of squat exercises is performed initially, followed by upper body strength training such as bench presses; each movement must be completed with the specified number of sets and repetitions before proceeding to the next exercise. Explosiveness training enhances the rapid contraction capabilities of the muscles through a series of jumping and throwing movements, while flexibility exercises improve the range of motion of muscles and joints through a combination of static and dynamic stretching.
Study NCT06667440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: Women in the intervention group will apply cryotherapy on their hypogastrium with a coldpack
Study NCT06672276 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQD3606
Description: TQD3606 is a fixed-dose combination of meropenem and avibactam. Meropenem is a carbapenem antimicrobial agent, and avibactam is a β-lactamase inhibitor.
Study NCT06671691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT level I
Description: 20Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique
Study NCT06671691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT level II
Description: 23Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique
Study NCT06671691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT level III
Description: 26Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique
Study NCT06671691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT level IV
Description: 28Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique
Study NCT06671691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT level V
Description: 30Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique
Study NCT06673004 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ovarian tissue allo-transplantation
Description: Participants will receive donor ovarian tissue with immunosuppression
Study NCT06672913 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: skin to skin contact care
Description: Early and regular skin to skin contact in NICU GA: \< 28 weeks: After the 72nd hour GA: 28 - 32 weeks: As soon as stabilization is ensured
Study NCT05152446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Infusion management scheme
Description: * To set up a pediatric intravenous infusion team;~* To form standardized procedures by carrying out a quality improvement program in collecting and sending samples for inspection once suspected CLABSI occurs (1 month for training and 3 months for continuous improvement ); providing infusion training curriculums to nurses in forms of lectures, group discussions, operation demonstrations, and scenario simulations, holding practice review meeting with them; providing elements to caregivers of educational leaflet, nurse-provided education during patients' infusion therapy( 6-month implementation);~* To observe the continued daily infusion practice in 6 months.
Study NCT06058845 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Tamarindus indica fruit juice_A
Description: The participants will be exposed to 10% Tamarind pulp juice
Study NCT06058845 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Tamarindus indica fruit juice_B
Description: The participants will be exposed to 30% Tamarind pulp juice
Study NCT05683561 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: CoronaVac
Description: D0; intramuscular injection
Study NCT05683561 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCTV01E
Description: D0; intramuscular injection
Study NCT04491422 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Integrated Next Steps Counseling with Real-Time Drug Level Feedback
Description: Integrated next steps counseling with real-time drug level feedback using point-of-care urine tenofovir testing at quarterly visits
Study NCT04976179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Description: Ferric carboxymaltose to be given as an intravenous infusion
Study NCT04976179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous sulfate
Description: Ferrous sulphate tablet to be taken orally
Study NCT04998526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: The cold gel pack will be applied to the nape.
Study NCT04998526 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: The gel pack kept at room temperature will be applied to the nape.
Study NCT04879927 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resource Matching
Description: Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.
Study NCT04879927 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.
Study NCT06258473 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: mHealth
Description: Training and support on Simple app for HTN/DM patient management \& training NCD corner clinicians on clinical guidelines of Upazila Health complex
Study NCT05896579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Exercise training will include supervised high-intensity interval training for \~35 minutes 3x/week on an upright stationary bicycle and unsupervised continuous aerobic exercise for \~30 minutes 2x/week.
Study NCT04726098 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone high dose
Description: High doses: dexamethasone 20 mg/day 5 days + 10 mg/day 5 days (total 10 days)
Study NCT04726098 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone low dose
Description: Low doses: dexamethasone 6 mg/day 10 days.
Study NCT06672302 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ExoPred
Description: Performing in vitro diagnostics with devices developed by EXoPERT
Study NCT06671860 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Individuals were randomly assigned to the REP (Routine Exercise Program) group and the OHP group. The REP group received the traditional exercise protocol and the OHP group received oculomotor exercises and myofascial release techniques in addition to the traditional exercise. The groups were evaluated before the treatment and at the end of the 6-week treatment sessions. Patient education was given to the patients before both programs. Patient education included information about nonspecific chronic neck pain, symptoms, and complications, as well as assessment methods, parameters, tests, and exercises.~The first group, the REP group (n=19), received routine exercises, and the second group, the OHP group (n=19), received oculomotor exercises and myofascial relaxation techniques in addition to the routine exercise program. The treatments were applied for six weeks, three sessions per week, under the supervision and guidance of a physiotherapist in the clinic.
Study NCT06671860 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Individuals were randomly assigned to the REP (Routine Exercise Program) group and the OHP group. The REP group received the traditional exercise protocol and the OHP group received oculomotor exercises and myofascial release techniques in addition to the traditional exercise. The groups were evaluated before the treatment and at the end of the 6-week treatment sessions. Patient education was given to the patients before both programs. Patient education included information about nonspecific chronic neck pain, symptoms, and complications, as well as assessment methods, parameters, tests, and exercises.~The first group, the REP group (n=19), received routine exercises, and the second group, the OHP group (n=19), received oculomotor exercises and myofascial relaxation techniques in addition to the routine exercise program. The treatments were applied for six weeks, three sessions per week, under the supervision and guidance of a physiotherapist in the clinic.
Study NCT04571762 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: SBRT (a fraction dose adapted to the OAR geometry-of-the-day, 5 fractions) performed on the MR-Linac
Study NCT04746547 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dolutegravir 50 MG
Description: Twice daily dolutegravir with rifampicin containing TB treatment
Study NCT04746547 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dolutegravir 10 MG
Description: Twice daily dolutegravir with rifampicin containing TB treatment
Study NCT06562374 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Frequency Ultrasound Therapy
Description: The ultrasound will be delivered at a frequency of 33 kHz at power levels of 4-10 Pascals with a program of 1.6 seconds on and 1.6 seconds off. The generators will be encased in epoxy within the Osteoarthritis baths. The intervention will be repeated on every second or third day to allow time for healing
Study NCT05770388 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: App Take Care of Your Mood
Description: The app provides psychoeducational information, contains several thematic modules (mindfulness, emotional regulation, healthy lifestyle habits, safety plan for crisis management, among others), allows mood monitoring, contains motivational messages and videos aimed at promoting help-seeking in mental health, and information on available support services.
Study NCT05770388 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: App Take Care of Your Mood
Description: The app provides psychoeducational information, contains several thematic modules (mindfulness, emotional regulation, healthy lifestyle habits, safety plan for crisis management, among others), allows mood monitoring, contains motivational messages and videos aimed at promoting help-seeking in mental health, and information on available support services.
Study NCT05770388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder messages and counseling
Description: Participants receive reminder messages (by email and chat) encouraging them to use the app and to request a counseling session (via phone call, videoconference or chat) with a clinical psychologist if they think it is necessary.
Study NCT05578443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10g Astragalus
Description: Astragalus tablets 10g, warm water to drink, once a day, take for 1 year, during which routine treatment should also be carried out.
Study NCT05578443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine treatment
Description: Limit water and sodium intake. Raise the head of the bed. Standardized amount of exercise. Low temperature diet and small meals. Avoid alcohol, coffee and dehydration. The treatment lasted for 3 months.
Study NCT05578443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20g Astragalus
Description: Astragalus tablets 20g, warm water to drink, once a day, take for 1 year, during which routine treatment should also be carried out.
Study NCT04724616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Program (CARTOON)
Description: CARTOON is an interdisciplinary psychoeducational intervention program. It consists of five teaching sessions: 1) hand hygiene, not grasping the face, 2) sneezing etiquette, 3) wearing a mask, 4) social distancing, and 5) theoretical knowledge about the coronavirus. Using special exercises and games, information about the coronavirus is conveyed in a child friendly manner.
Study NCT06354023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone
Description: All participants will receive six weeks of treatment. Once per week, they will receive one intra-articular injection of 2cc (15IU) recombinant human growth hormone in their affected knee. The injection will also contain 1cc (1%) Lidocaine and 1cc (0.5%) Marcaine and Epinephrine for anesthetic purposes. The participants will receive a total of 6 growth hormone injections.
Study NCT06201234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib + Elacestrant
Description: Olaparib 600 mg orally daily and elacestrant 400 mg orally daily
Study NCT06201234 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olaparib
Description: Olaparib 600 mg orally daily
Study NCT05200351 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Equine assisted Therapy (EAT)
Description: 15 sessions of EAT will be given. Activities will be with or in the presence of the horse. There will be no horseriding.
Study NCT05105243 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CVN766
Description: highly selective orexin-1 receptor (Ox1R) antagonist
Study NCT05105243 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CVN766
Description: highly selective orexin-1 receptor (Ox1R) antagonist
Study NCT05666115 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic group
Description: During the first 4 weeks, patients will be instructed to take two capsules of Enterelle plus (Bromatech lab, Manno, Switzerland) during morning time, before or after breakfast. Enterelle plus contains specific strains, i.e., S boulardi, E faecium, and acidophilus, that contribute to reduce the mycotic flora and modulate the gastrointestinal transit. For the next 8 weeks, participants will be told to ingest two capsules of Adomelle (Bromatech lab, Manno, Switzerland) at night, during or right after dinner. Adomelle contains several strains, including Bifidobacterium breve, that help to reduce abdominal fat, pain, and gas, and control the frequency of deposition
Study NCT05666115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise group
Description: This type of intervention has shown to benefit patients with several chronic conditions 23, including axSpA 13. Exercises combined high knees, lunges, basic burpees, plank, skipping, mountain climbers, and squats with jumps. The training routine will be conducted three times per week, and each session will last around 8 minutes (2 sets of 4 minutes, with a 10 second rest between them). All sessions will be individually tailored and supervised by a senior professional with a degree in Physiotherapy and Sciences of Physical Activity and Sport. Overall, participants will be told to continue exercising if low to moderate bearable pain appeared during training.
Study NCT05253326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercises
Description: It is among the relaxation techniques that require the active participation of the individual.
Study NCT05779943 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: Given IV
Study NCT05779943 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: F18-rhPSMA-7.3
Description: Given IV
Study NCT05779943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT scan
Study NCT05779943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT scan
Study NCT05169931 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RegenerEyes
Description: Biologic eye drop
Study NCT06042231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Intervention
Description: Exercise and education intervention. Participants will be prescribed a tailored exercise program to complete before ('pre-habilitation') and after their AF ablation procedure (rehabilitation).
Study NCT06042231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education Intervention
Description: Education intervention. Participants will be given a 1-1 education session (up to 3 sessions) before and after their AF ablation procedure. Participants will be given behavioural strategies to improve adherence and compliancec to risk-factor modification.
Study NCT05154890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegtarviliase IV
Description: Administered IV
Study NCT05154890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegtarviliase SC
Description: Administered SC
Study NCT06289296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fatty acid intake in lean and obese males
Description: Acute and chronic intake of MCT and LCT
Study NCT06562959 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Fluid Restriction Program
Description: In order to design the fluid restriction program content (booklet). The fluid restriction program included (a) General small-group discussion sessions, (b) individualized consultations, and (c) follow-up sessions. In the group discussion sessions, children in both the study and control groups were divided into subgroups (6 participants per each). In the group discussion sessions, children in both the study and control groups were divided into subgroups. The sessions were conducted in the meeting room of the Hemodialysis unit lasts for 45 minutes. In the Individualized Consultations, children then were provided tailored, age-appropriate education. The researchers also arranged for regular follow-up for one months.
Study NCT06562959 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Bundle (Fluid Restriction Program and Auricular Acupressure
Description: the study group received the Fluid Restriction Program and Auricular Acupressure in four acupoints namely, Shenmen, Kidney Concha, Point Zero and Upper Tragus. The researcher's finger gently pressed on each determined acupoints in a circular movement with a clockwise direction for three minutes.
Study NCT06272617 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: verum acupuncture
Description: a type of acupuncture which is useful
Study NCT06272617 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham acupuncture
Description: a type of acupuncture which is useless
Study NCT06468254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Statin
Description: Statin Group: Conventional chemotherapy and maintenance therapy combined with statins.
Study NCT06468254 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sugar pill
Description: Control Group: Conventional chemotherapy and maintenance therapy alone.
Study NCT06389448 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: pCLE-gastr
Description: After identifying the location of the lesion through white light endoscopy, the pCLE operation is performed to acquire images from the specific gastric lesions, and finally the ESD routine is performed.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Verum T1
Description: Verum T1 is a placebo: microcristalline cellulose. Daily dosage is 1000 mg in 3 capsules.
Study NCT04914416 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Verum T1
Description: Verum T1 is a placebo: microcristalline cellulose. Daily dosage is 1000 mg in 3 capsules.
Study NCT05581407 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TETRALITE
Description: LiteVax Adjuvanted Seasonal Influenza Vaccine
Study NCT05581407 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: TETRALITE
Description: LiteVax Adjuvanted Seasonal Influenza Vaccine
Study NCT03192007 — intervention group
Intervention type: DEVICE
Intervention: Magnetic Resonance Imaging
Description: Investigate anatomic and functional characteristics of transplant kidneys using MRI